RSS   Newsletter   Contact   Advertise with us
Post Online Media

Voyager Therapeutics appoints Matthew P. Ottmer as COO

Matthew P. OttmerSeptember 19, 2017, Cambridge, Mass., USA - Voyager Therapeutics, a clinical-stage gene therapy company, announced the appointment of Matthew P. Ottmer as chief operating officer.
Mr. Ottmer brings to Voyager more than 18 years of biotechnology industry experience.

Mr. Ottmer joins Voyager most recently from Momenta Pharmaceuticals, Inc., where he was chief operating officer, responsible for program and alliance management, research, clinical development, pharmaceutical sciences and commercial activities since late 2015.

Prior to this role, Mr. Ottmer spent 16 years at Biogen in a variety of leadership roles, including as senior vice president, strategy and emerging businesses, head of Tysabri business, chief of staff to the chief executive officer, president of Syntonix Pharmaceuticals, a wholly owned subsidiary of Biogen, now Bioverativ,, and vice president of global operations.

He received a Bachelor of Arts degree in political science from the University of Michigan and a Master's in Business Administration from Northwestern University’s Kellogg School of Management.

 

 LATEST MOVES FROM Massachusetts 


 
 

POST Online Media does not use cookies to collect information about visitors.   OK, hide this message   Third party ads may be using cookies, you can see how here.